Skip to content
⌘ K

By Intermission· 903 words

ResearchEvidenceQuestion

Why do pancreatic beta cells fail?

Evidence(8)

  1. Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes? | Nature Reviews Endocrinology

    [1]

    Summary

    In type 1 diabetes, alpha and beta cells both become dysfunctional, but beta cells die. Alpha cells express more antiapoptotic BCL2L1, protective BiP, antiviral genes, and immune-inhibitory HLA-E. Beta cells show more proapoptotic CHOP, while invading CD8 T cells recognize preproinsulin rather than glucagon, concentrating immunogenic stress on beta cells.

    1

    Bearing

    It answers the selectivity problem through unequal resilience and antigenicity, not a beta-cell-only immune mechanism. Lower antiapoptotic, chaperone, antiviral, and HLA-E defenses leave beta cells less able to survive ER or viral stress. Preproinsulin-specific T-cell recognition then adds targeted pressure. The preview supports this synthesis at abstract level.

  2. The immunology of type 1 diabetes | Nature Reviews Immunology

    [2]

    Summary

    This review surveys type 1 diabetes immune mechanisms, emphasizing T cells and autoimmune beta-cell destruction. It connects T-cell-directed treatment with delayed disease progression and calls for better immunobiology and monitoring of residual beta-cell mass and function. The available preview supports these broad conclusions, not detailed cellular mechanisms.

  3. The role of the beta cell in type 2 diabetes: new findings from the last 5 years | Diabetologia | Springer Nature Link

    [3]

    Summary

    This human-focused review places beta-cell dysfunction at the centre of type 2 diabetes. Early insulin-secretory abnormalities can precede reduced beta-cell mass. Risk variants, intra-islet and inter-organ signals, heterogeneity, and sex-related responses shape vulnerability. Clinical evidence shows weight loss and incretin-based therapies can restore function and produce remission.

  4. Checking your browser - reCAPTCHA

    [4]

    Summary

    This frozen page contains a browser-verification challenge rather than article text. It identifies no beta-cell findings, study methods, results, or references. Consequently, it provides no substantive evidence about pancreatic beta-cell failure.

  5. From human to mouse and back: genetic and genomic ta(i)les of islet dysfunction in type 2 diabetes - PMC

    [5]

    Summary

    This review frames type 2 diabetes beta-cell failure as genetically patterned islet dysfunction interacting with environment. Human and mouse genomics connect risk variants to insulin synthesis, proinsulin processing, secretion, mitochondrial maintenance, stress responses, and apoptosis. Multi-omic and context-specific analyses reveal heterogeneous pathways, while model differences limit direct translation.

  6. The role of the beta cell in type 2 diabetes: new findings from the last 5 years - PMC

    [6]

    Summary

    In type 2 diabetes, early beta-cell dysfunction and inadequate insulin secretion drive hyperglycaemia before beta-cell mass loss. Genetic variants affect development, secretion, and stress resilience. Signals from islets, exocrine pancreas, gut, and insulin-sensitive tissues compound defects, while heterogeneous stress responses help explain progression and remission after weight loss or incretin treatment.

  7. The β-Cell in Type 1 Diabetes Pathogenesis: A Victim of Circumstances or an Instigator of Tragic Events? - PMC

    [7]

    Summary

    Type 1 diabetes beta-cell failure reflects reciprocal T-cell and beta-cell activity. High insulin-production demands create ER and oxidative stress, while inflammatory mediators and beta-cell antigen release can intensify autoimmunity. Beta cells may initiate, amplify, and finally complete their destruction through intrinsic stress and death, although protective responses can delay progression.

  8. Βeta-Cells: Stress, Identity, Failure and Diabetes - PMC

    [8]

    Summary

    This review describes type 2 diabetes beta-cell failure as a shift from compensation to chronic stress. Glucotoxicity, lipotoxicity, ER and mitochondrial dysfunction, inflammation, senescence, and altered islet interactions reduce insulin production and secretion. Loss of beta-cell identity and heterogeneous stress responses help determine whether cells adapt, dedifferentiate, or die.

Sources

  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.
  7. 7.
  8. 8.

Comments

LatestPopular
Write a comment
Loading comments…

Request a Thesis

Tell us what you’d like Roadstar to investigate.

New question

What would you like to know?

Context guides the research and is not shown on the finished page.